-
Signature
-
/s/ Chase Rosson by Power of Attorney
-
Issuer symbol
-
ICHR
-
Transactions as of
-
14 Feb 2025
-
Net transactions value
-
-$903,593
-
Form type
-
4
-
Filing time
-
19 Feb 2025, 17:33:17 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Options Exercise |
$1,944,606 |
+78,128 |
+164% |
$24.89 |
125,815 |
14 Feb 2025 |
Direct |
F1 |
| transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Options Exercise |
$1,166,644 |
+46,872 |
+37% |
$24.89 |
172,687 |
14 Feb 2025 |
Direct |
|
| transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Sale |
$2,498,533 |
-78,128 |
-45% |
$31.98 |
94,559 |
14 Feb 2025 |
Direct |
F1 |
| transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Sale |
$1,516,309 |
-46,872 |
-50% |
$32.35 |
47,687 |
18 Feb 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ICHR |
Option (right to buy) |
Options Exercise |
$0 |
-78,128 |
-63% |
$0.000000 |
46,872 |
14 Feb 2025 |
Ordinary Shares, par value $0.0001 |
78,128 |
$24.89 |
Direct |
F1, F2 |
| transaction |
ICHR |
Option (right to buy) |
Options Exercise |
$0 |
-46,872 |
-100% |
$0.000000 |
0 |
14 Feb 2025 |
Ordinary Shares, par value $0.0001 |
46,872 |
$24.89 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: